TY - JOUR
T1 - A clinical analysis of sinonasal squamous cell carcinoma
T2 - a comparison of de novo squamous cell carcinoma and squamous cell carcinoma arising from inverted papilloma
AU - Yasumatsu, Ryuji
AU - Jiromaru, Rina
AU - Hongo, Takahiro
AU - Uchi, Ryutaro
AU - Wakasaki, Takahiro
AU - Matsuo, Mioko
AU - taura, masahiko
AU - Nakagawa, Takashi
N1 - Publisher Copyright:
© 2020 Acta Oto-Laryngologica AB (Ltd).
PY - 2020/7/31
Y1 - 2020/7/31
N2 - Background: Sinonasal squamous cell carcinoma (SCC) is a rare tumor arising either de novo or in association with inverted papillomas (IPs). Objectives: The aim of this study was to investigate and compare the oncological features and prognosis of patients with sinonasal SCCs based on their etiology. Material and methods: The medical records of 117 patients who had been diagnosed with de novo SCC or those arising from IP (IP-SCC) were retrospectively reviewed. In situ hybridization analyses to detect HPV 16/18DNA and p16 immunohistochemistry were also performed in 10 cases with IP-SCC. Results: The three-year disease-specific survival (DSS) rate was higher in cases with T1, 2 and 3 than in cases with T4 in both tumor groups. T4 cases with de novo SCC had a better DSS than those with IP-SCCs. HPV16/18 was not detected in any of the 10 IP-SCCs. Conclusions and significance: T4 cases with de novo SCC tended to have a better DSS than those with IP-SCC. Since some T4 patients with IP-SCC were found to have a highly aggressive disease, careful treatment planning should be performed. High-risk HPV may not play a vital role in the carcinomatous transformation of most IP-SCC cases.
AB - Background: Sinonasal squamous cell carcinoma (SCC) is a rare tumor arising either de novo or in association with inverted papillomas (IPs). Objectives: The aim of this study was to investigate and compare the oncological features and prognosis of patients with sinonasal SCCs based on their etiology. Material and methods: The medical records of 117 patients who had been diagnosed with de novo SCC or those arising from IP (IP-SCC) were retrospectively reviewed. In situ hybridization analyses to detect HPV 16/18DNA and p16 immunohistochemistry were also performed in 10 cases with IP-SCC. Results: The three-year disease-specific survival (DSS) rate was higher in cases with T1, 2 and 3 than in cases with T4 in both tumor groups. T4 cases with de novo SCC had a better DSS than those with IP-SCCs. HPV16/18 was not detected in any of the 10 IP-SCCs. Conclusions and significance: T4 cases with de novo SCC tended to have a better DSS than those with IP-SCC. Since some T4 patients with IP-SCC were found to have a highly aggressive disease, careful treatment planning should be performed. High-risk HPV may not play a vital role in the carcinomatous transformation of most IP-SCC cases.
UR - http://www.scopus.com/inward/record.url?scp=85084853775&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85084853775&partnerID=8YFLogxK
U2 - 10.1080/00016489.2020.1758342
DO - 10.1080/00016489.2020.1758342
M3 - Article
C2 - 32400256
AN - SCOPUS:85084853775
SN - 0001-6489
VL - 140
SP - 706
EP - 711
JO - Acta Oto-Laryngologica
JF - Acta Oto-Laryngologica
IS - 8
ER -